Related Experiment Videos
HTLV-II and human lymphoproliferative disorders
J D Rosenblatt1, I S Chen, D W Golde
1Department of Medicine, UCLA School of Medicine.
Clinics in Laboratory Medicine
|March 1, 1988
Summary
Human T-lymphotropic virus type II (HTLV-II) is an uncommon retrovirus associated with T-cell cancers. Its prevalence is rising, especially among intravenous drug users, prompting further comparative research.
Area of Science:
- * Virology
- * Oncology
- * Immunology
Background:
- * Human T-lymphotropic virus type II (HTLV-II) is a retrovirus infrequently diagnosed.
- * HTLV-II is associated with specific leukemias and T-cell malignancies.
- * Recent increases in HTLV-II prevalence are noted, particularly in intravenous drug abuser populations.
Purpose of the Study:
- * To compare Human T-lymphotropic virus type II (HTLV-II) with HTLV-I.
- * To gain insights into retroviral replication mechanisms.
- * To understand T-cell transformation processes.
Main Methods:
- * Comparative analysis of HTLV-I and HTLV-II.
- * Epidemiological data on HTLV-II prevalence.
- * Studies on retroviral replication and T-cell transformation.
Main Results:
- * HTLV-II is linked to rare forms of hairy-cell leukemia and T-cell cancers.
- * A rise in HTLV-II prevalence has been observed in the US, especially among intravenous drug users.
- * Comparative studies yield insights into viral replication and T-cell transformation.
Conclusions:
- * HTLV-II, though rare, has significant associations with hematologic malignancies.
- * Increasing prevalence warrants further investigation into transmission and pathogenesis.
- * Comparative studies are crucial for understanding retroviral mechanisms.